FDA inspection
AstraZeneca Pharmaceuticals LP MQSA: FDA inspection ending Oct 2, 2012
FDA inspection 804479 · Wilmington, DE
Key facts
| Inspection ID | 804479 |
|---|---|
| Firm | AstraZeneca Pharmaceuticals LP MQSA |
| FEI number | 1000522430 |
| Address | 1800 Concord Pike |
| City | Wilmington |
| State | DE |
| ZIP | 19897-0001 |
| Fiscal year | 2013 |
| Inspection end date | Oct 2, 2012 |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data